Correlation Engine 2.0
Clear Search sequence regions

  • and disease (1)
  • insulin (7)
  • lipogenesis (7)
  • liver (1)
  • liver disease (3)
  • Lsd1 (2)
  • mice (2)
  • Sizes of these terms reflect their relevance to your search.

    Hepatic de novo lipogenesis is a major contributor to nonalcoholic fatty liver disease (NAFLD). In this issue of the JCI, Liu and Lin et al. identified Slug as an epigenetic regulator of lipogenesis. Their findings suggest that Slug is stabilized by insulin signaling, and that it promotes lipogenesis by recruiting the histone demethylase Lsd1 to the fatty acid synthase gene promoter. On the other hand, genetic deletion or acute depletion of Slug, or Lsd1 inhibition, reduced lipogenesis and protected against obesity-associated NAFLD and insulin resistance in mice. This study advances our understanding of how lipogenesis is regulated downstream of insulin signaling in health and disease.


    Clarence R Manuel, Rebecca A Haeusler. Insulin-stimulated lipogenesis gets an epigenetic makeover. The Journal of clinical investigation. 2020 Jun 01;130(6):2809-2810

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32364539

    View Full Text